-
Antibacterial effect of polyphenols extracted from different honeys against methicillin-resistant staphylococcus aureus
Belkhodja H, Belmimoun A and Meddah B
Research Article: Clinical Investigation
-
Antibacterial effect of polyphenols extracted from different honeys against methicillin-resistant staphylococcus aureus
Belkhodja H, Belmimoun A and Meddah B
Research Article: Clinical Investigation
-
Antibacterial effect of polyphenols extracted from different honeys against methicillin-resistant staphylococcus aureus
Belkhodja H, Belmimoun A and Meddah B
Research Article: Clinical Investigation
-
Antibacterial effect of polyphenols extracted from different honeys against methicillin-resistant staphylococcus aureus
Belkhodja H, Belmimoun A and Meddah B
Research Article: Clinical Investigation
-
Antibacterial effect of polyphenols extracted from different honeys against methicillin-resistant staphylococcus aureus
Belkhodja H, Belmimoun A and Meddah B
Research Article: Clinical Investigation
-
Antibacterial effect of polyphenols extracted from different honeys against methicillin-resistant staphylococcus aureus
Belkhodja H, Belmimoun A and Meddah B
Research Article: Clinical Investigation
-
Antibacterial effect of polyphenols extracted from different honeys against methicillin-resistant staphylococcus aureus
Belkhodja H, Belmimoun A and Meddah B
Research Article: Clinical Investigation
-
Antibacterial effect of polyphenols extracted from different honeys against methicillin-resistant staphylococcus aureus
Belkhodja H, Belmimoun A and Meddah B
Research Article: Clinical Investigation
-
Controlled multiple imputation methods for sensitivity analyses in longitudinal clinical trials with dropout and protocol deviation
Michael G Kenward
Clinical Trail Methodology: Clinical Investigation
-
Controlled multiple imputation methods for sensitivity analyses in longitudinal clinical trials with dropout and protocol deviation
Michael G Kenward
Clinical Trail Methodology: Clinical Investigation
-
Controlled multiple imputation methods for sensitivity analyses in longitudinal clinical trials with dropout and protocol deviation
Michael G Kenward
Clinical Trail Methodology: Clinical Investigation
-
Controlled multiple imputation methods for sensitivity analyses in longitudinal clinical trials with dropout and protocol deviation
Michael G Kenward
Clinical Trail Methodology: Clinical Investigation
-
Controlled multiple imputation methods for sensitivity analyses in longitudinal clinical trials with dropout and protocol deviation
Michael G Kenward
Clinical Trail Methodology: Clinical Investigation
-
Controlled multiple imputation methods for sensitivity analyses in longitudinal clinical trials with dropout and protocol deviation
Michael G Kenward
Clinical Trail Methodology: Clinical Investigation
-
Controlled multiple imputation methods for sensitivity analyses in longitudinal clinical trials with dropout and protocol deviation
Michael G Kenward
Clinical Trail Methodology: Clinical Investigation
-
Controlled multiple imputation methods for sensitivity analyses in longitudinal clinical trials with dropout and protocol deviation
Michael G Kenward
Clinical Trail Methodology: Clinical Investigation
-
Non-inferiority designs and novel antimicrobials
Giorgio Tarchini
Editorial: Clinical Investigation
-
Non-inferiority designs and novel antimicrobials
Giorgio Tarchini
Editorial: Clinical Investigation
-
Non-inferiority designs and novel antimicrobials
Giorgio Tarchini
Editorial: Clinical Investigation
-
Non-inferiority designs and novel antimicrobials
Giorgio Tarchini
Editorial: Clinical Investigation
-
Non-inferiority designs and novel antimicrobials
Giorgio Tarchini
Editorial: Clinical Investigation
-
Non-inferiority designs and novel antimicrobials
Giorgio Tarchini
Editorial: Clinical Investigation
-
Non-inferiority designs and novel antimicrobials
Giorgio Tarchini
Editorial: Clinical Investigation
-
Non-inferiority designs and novel antimicrobials
Giorgio Tarchini
Editorial: Clinical Investigation
-
Research integrity in the modern era: current gaps in our knowledge and thinking
Marisa Kardos Garshick and Alexa Boer Kimball
Editorial: Clinical Investigation
-
Research integrity in the modern era: current gaps in our knowledge and thinking
Marisa Kardos Garshick and Alexa Boer Kimball
Editorial: Clinical Investigation
-
Research integrity in the modern era: current gaps in our knowledge and thinking
Marisa Kardos Garshick and Alexa Boer Kimball
Editorial: Clinical Investigation
-
Research integrity in the modern era: current gaps in our knowledge and thinking
Marisa Kardos Garshick and Alexa Boer Kimball
Editorial: Clinical Investigation
-
Research integrity in the modern era: current gaps in our knowledge and thinking
Marisa Kardos Garshick and Alexa Boer Kimball
Editorial: Clinical Investigation
-
Research integrity in the modern era: current gaps in our knowledge and thinking
Marisa Kardos Garshick and Alexa Boer Kimball
Editorial: Clinical Investigation
-
Research integrity in the modern era: current gaps in our knowledge and thinking
Marisa Kardos Garshick and Alexa Boer Kimball
Editorial: Clinical Investigation
-
Research integrity in the modern era: current gaps in our knowledge and thinking
Marisa Kardos Garshick and Alexa Boer Kimball
Editorial: Clinical Investigation
-
New approaches to the design of clinical trials in idiopathic pulmonary fibrosis
Stefania Cerri, Cinzia Del Giovane, Sara Balduzzi, Francesco Soncini, Antonia Sdanganelli, Luca Richeldi
News and Views: Clinical Investigation
-
New approaches to the design of clinical trials in idiopathic pulmonary fibrosis
Stefania Cerri, Cinzia Del Giovane, Sara Balduzzi, Francesco Soncini, Antonia Sdanganelli, Luca Richeldi
News and Views: Clinical Investigation
-
New approaches to the design of clinical trials in idiopathic pulmonary fibrosis
Stefania Cerri, Cinzia Del Giovane, Sara Balduzzi, Francesco Soncini, Antonia Sdanganelli, Luca Richeldi
News and Views: Clinical Investigation
-
New approaches to the design of clinical trials in idiopathic pulmonary fibrosis
Stefania Cerri, Cinzia Del Giovane, Sara Balduzzi, Francesco Soncini, Antonia Sdanganelli, Luca Richeldi
News and Views: Clinical Investigation
-
New approaches to the design of clinical trials in idiopathic pulmonary fibrosis
Stefania Cerri, Cinzia Del Giovane, Sara Balduzzi, Francesco Soncini, Antonia Sdanganelli, Luca Richeldi
News and Views: Clinical Investigation
-
New approaches to the design of clinical trials in idiopathic pulmonary fibrosis
Stefania Cerri, Cinzia Del Giovane, Sara Balduzzi, Francesco Soncini, Antonia Sdanganelli, Luca Richeldi
News and Views: Clinical Investigation
-
New approaches to the design of clinical trials in idiopathic pulmonary fibrosis
Stefania Cerri, Cinzia Del Giovane, Sara Balduzzi, Francesco Soncini, Antonia Sdanganelli, Luca Richeldi
News and Views: Clinical Investigation
-
New approaches to the design of clinical trials in idiopathic pulmonary fibrosis
Stefania Cerri, Cinzia Del Giovane, Sara Balduzzi, Francesco Soncini, Antonia Sdanganelli, Luca Richeldi
News and Views: Clinical Investigation
-
Placebo mechanisms for drug dose reduction: what is the evidence?
Paul Enck, Sibylle Klosterhalfen
Commentary: Clinical Investigation
-
Placebo mechanisms for drug dose reduction: what is the evidence?
Paul Enck, Sibylle Klosterhalfen
Commentary: Clinical Investigation
-
Placebo mechanisms for drug dose reduction: what is the evidence?
Paul Enck, Sibylle Klosterhalfen
Commentary: Clinical Investigation
-
Placebo mechanisms for drug dose reduction: what is the evidence?
Paul Enck, Sibylle Klosterhalfen
Commentary: Clinical Investigation
-
Placebo mechanisms for drug dose reduction: what is the evidence?
Paul Enck, Sibylle Klosterhalfen
Commentary: Clinical Investigation
-
Placebo mechanisms for drug dose reduction: what is the evidence?
Paul Enck, Sibylle Klosterhalfen
Commentary: Clinical Investigation
-
Placebo mechanisms for drug dose reduction: what is the evidence?
Paul Enck, Sibylle Klosterhalfen
Commentary: Clinical Investigation
-
Placebo mechanisms for drug dose reduction: what is the evidence?
Paul Enck, Sibylle Klosterhalfen
Commentary: Clinical Investigation
-
Considerations in the design of clinical trials for erectile dysfunction
Naif Alhathal, Talal Al-Qaoud,Serge Carrier
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for erectile dysfunction
Naif Alhathal, Talal Al-Qaoud,Serge Carrier
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for erectile dysfunction
Naif Alhathal, Talal Al-Qaoud,Serge Carrier
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for erectile dysfunction
Naif Alhathal, Talal Al-Qaoud,Serge Carrier
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for erectile dysfunction
Naif Alhathal, Talal Al-Qaoud,Serge Carrier
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for erectile dysfunction
Naif Alhathal, Talal Al-Qaoud,Serge Carrier
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for erectile dysfunction
Naif Alhathal, Talal Al-Qaoud,Serge Carrier
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for erectile dysfunction
Naif Alhathal, Talal Al-Qaoud,Serge Carrier
Clinical Trail Methodology: Clinical Investigation
-
Research involving pregnant women: trials and tribulations
Francoise Baylis, Scott A. Halperin
Clinical Trail Perspective: Clinical Investigation
-
Research involving pregnant women: trials and tribulations
Francoise Baylis, Scott A. Halperin
Clinical Trail Perspective: Clinical Investigation
-
Research involving pregnant women: trials and tribulations
Francoise Baylis, Scott A. Halperin
Clinical Trail Perspective: Clinical Investigation
-
Research involving pregnant women: trials and tribulations
Francoise Baylis, Scott A. Halperin
Clinical Trail Perspective: Clinical Investigation
-
Research involving pregnant women: trials and tribulations
Francoise Baylis, Scott A. Halperin
Clinical Trail Perspective: Clinical Investigation
-
Research involving pregnant women: trials and tribulations
Francoise Baylis, Scott A. Halperin
Clinical Trail Perspective: Clinical Investigation
-
Research involving pregnant women: trials and tribulations
Francoise Baylis, Scott A. Halperin
Clinical Trail Perspective: Clinical Investigation
-
Research involving pregnant women: trials and tribulations
Francoise Baylis, Scott A. Halperin
Clinical Trail Perspective: Clinical Investigation
-
New and emerging therapies for gout
Daria B Crittenden, Han Na Kim, Mark C Fisher, David S Goldfarb, Michael H Pillinger
Review Article: Clinical Investigation
-
New and emerging therapies for gout
Daria B Crittenden, Han Na Kim, Mark C Fisher, David S Goldfarb, Michael H Pillinger
Review Article: Clinical Investigation
-
New and emerging therapies for gout
Daria B Crittenden, Han Na Kim, Mark C Fisher, David S Goldfarb, Michael H Pillinger
Review Article: Clinical Investigation
-
New and emerging therapies for gout
Daria B Crittenden, Han Na Kim, Mark C Fisher, David S Goldfarb, Michael H Pillinger
Review Article: Clinical Investigation
-
New and emerging therapies for gout
Daria B Crittenden, Han Na Kim, Mark C Fisher, David S Goldfarb, Michael H Pillinger
Review Article: Clinical Investigation
-
New and emerging therapies for gout
Daria B Crittenden, Han Na Kim, Mark C Fisher, David S Goldfarb, Michael H Pillinger
Review Article: Clinical Investigation
-
New and emerging therapies for gout
Daria B Crittenden, Han Na Kim, Mark C Fisher, David S Goldfarb, Michael H Pillinger
Review Article: Clinical Investigation
-
New and emerging therapies for gout
Daria B Crittenden, Han Na Kim, Mark C Fisher, David S Goldfarb, Michael H Pillinger
Review Article: Clinical Investigation
-
Emerging therapies for head and neck cancer: review of the Phase II and III trials
Nicole G Chau, Bonnie S Glisson
Review Article: Clinical Investigation
-
Emerging therapies for head and neck cancer: review of the Phase II and III trials
Nicole G Chau, Bonnie S Glisson
Review Article: Clinical Investigation
-
Emerging therapies for head and neck cancer: review of the Phase II and III trials
Nicole G Chau, Bonnie S Glisson
Review Article: Clinical Investigation
-
Emerging therapies for head and neck cancer: review of the Phase II and III trials
Nicole G Chau, Bonnie S Glisson
Review Article: Clinical Investigation
-
Emerging therapies for head and neck cancer: review of the Phase II and III trials
Nicole G Chau, Bonnie S Glisson
Review Article: Clinical Investigation
-
Emerging therapies for head and neck cancer: review of the Phase II and III trials
Nicole G Chau, Bonnie S Glisson
Review Article: Clinical Investigation
-
Emerging therapies for head and neck cancer: review of the Phase II and III trials
Nicole G Chau, Bonnie S Glisson
Review Article: Clinical Investigation
-
Emerging therapies for head and neck cancer: review of the Phase II and III trials
Nicole G Chau, Bonnie S Glisson
Review Article: Clinical Investigation